Insufficient scRNA-seq data for expression of SLC25A30 at single-cell level.
Insufficient scRNA-seq data for expression of SLC25A30 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 1321.44 | 245 / 245 | 100% | 16.04 | 500 / 502 |
kidney | 100% | 3201.04 | 89 / 89 | 99% | 23.18 | 890 / 901 |
liver | 100% | 2506.87 | 226 / 226 | 96% | 18.53 | 389 / 406 |
skin | 100% | 1105.82 | 1807 / 1809 | 95% | 15.83 | 449 / 472 |
breast | 100% | 1270.47 | 459 / 459 | 95% | 9.93 | 1062 / 1118 |
pancreas | 98% | 575.33 | 323 / 328 | 94% | 6.92 | 168 / 178 |
lung | 99% | 1136.90 | 575 / 578 | 91% | 6.26 | 1054 / 1155 |
thymus | 100% | 1061.32 | 653 / 653 | 89% | 7.31 | 540 / 605 |
brain | 99% | 678.80 | 2606 / 2642 | 89% | 5.11 | 625 / 705 |
adrenal gland | 100% | 1315.64 | 258 / 258 | 84% | 7.56 | 194 / 230 |
uterus | 100% | 1416.05 | 170 / 170 | 83% | 5.79 | 379 / 459 |
esophagus | 100% | 778.69 | 1442 / 1445 | 80% | 4.47 | 147 / 183 |
stomach | 100% | 734.72 | 358 / 359 | 76% | 4.33 | 217 / 286 |
bladder | 100% | 972.10 | 21 / 21 | 74% | 4.51 | 373 / 504 |
intestine | 100% | 944.90 | 966 / 966 | 72% | 4.36 | 377 / 527 |
ovary | 100% | 1595.29 | 180 / 180 | 71% | 3.80 | 304 / 430 |
adipose | 100% | 1442.60 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1526.68 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 1408.23 | 241 / 241 | 0% | 0 | 0 / 0 |
muscle | 100% | 2881.86 | 801 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 3559.41 | 851 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 85% | 9.39 | 68 / 80 |
tonsil | 0% | 0 | 0 / 0 | 67% | 3.77 | 30 / 45 |
lymph node | 0% | 0 | 0 / 0 | 62% | 6.11 | 18 / 29 |
peripheral blood | 60% | 513.70 | 553 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0008150 | Biological process | biological_process |
GO_0055085 | Biological process | transmembrane transport |
GO_0015698 | Biological process | inorganic anion transport |
GO_0005743 | Cellular component | mitochondrial inner membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0005452 | Molecular function | solute:inorganic anion antiporter activity |
GO_0005515 | Molecular function | protein binding |
GO_0022857 | Molecular function | transmembrane transporter activity |
GO_0003674 | Molecular function | molecular_function |
Gene name | SLC25A30 |
Protein name | Kidney mitochondrial carrier protein 1 (Solute carrier family 25 member 30) (Uncoupling protein 6) Solute carrier family 25 member 30 |
Synonyms | UCP6 KMCP1 |
Description | FUNCTION: Antiporter that transports inorganic anions (sulfate, sulfite, thiosulfate and phosphate) and, to a lesser extent, a variety of dicarboxylates (e.g. malonate, malate and citramalate) and, even more so, aspartate . The sulfate/sulfate exchange is much higher than the phosphate/phosphate and malate/malate exchanges . The transport affinities is higher for sulfate and thiosulfate than for any other substrate . May catalyze the export of sulfite and thiosulfate (the hydrogen sulfide degradation products) from the mitochondria, thereby modulating the level of the hydrogen sulfide (Probable). Also may mediate a very low unidirectional transport of sulfate, phosphate and (S)-malate . . |
Accessions | ENST00000618165.1 E5RIS9 ENST00000522438.1 ENST00000310862.11 ENST00000463262.1 ENST00000519676.6 [Q5SVS4-1] ENST00000519547.5 E5RIW6 D6RJI0 ENST00000539591.5 [Q5SVS4-2] A0A087WWR9 Q5SVS4 |